Prilosec, Omeprazole
Prilosec, Omeprazole Newswire

Prilosec, Omeprazole Newswire

Comprehensive Real-Time News Feed for Prilosec, Omeprazole (generic).

Results 1 - 20 of 78 in Prilosec, Omeprazole (generic)

  1. FAQ: Heartburn Meds and Health RisksRead the original story

    9 hrs ago | KRMG-AM Tulsa

    July 6, 2015 -- About 21 million Americans have used prescription heartburn medications called proton pump inhibitors to help ease pain and discomfort after they eat. But does that help come at a price? A recent study found that the drugs, also known as PPIs, are linked to a higher heart attack risk.

    Comment?

  2. Drs. Roizen and Oz: The risks of PPIs; when and how to use the emergency roomRead the original story w/Photo

    Yesterday | Fort Wayne News-Sentinel

    Q: My dad has been taking an acid reflux medication for years, and he recently had a heart attack. I heard those meds can raise that risk.

    Comment?

  3. -story-blockRead the original story w/Photo

    Wednesday Jun 10 | The San Diego Union-Tribune

    A popular kind of heartburn medication is linked to a higher rate of heart attacks, according to a data-mining study led by Stanford University School of Medicine researchers. These drugs, which include Prilosec, known generically as omeprazole, belong to a class called proton pump inhibitors.

    Comment?

  4. esomeprazoleRead the original story w/Photo

    Tuesday Jun 30 | MedicineNet

    Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

    Comment?

  5. Some Heartburn Drugs May Boost Risk of Heart AttackRead the original story w/Photo

    Monday Jun 15 | Bioscience Technology

    A large data-mining study carried out by investigators at the Stanford University School of Medicine has linked a popular class of heartburn drugs to an elevated risk of heart attack. Proton-pump inhibitors, or PPIs, are among the world's most widely prescribed drugs, with $14 billion in annual sales.

    Comment?

  6. P&G product, other heartburn meds linked to risk of heart attackRead the original story w/Photo

    Friday Jun 12 | Business Journal

    A Procter & Gamble Co. product designed to prevent heartburn could elevate the risk of heart attack, according to a Stanford University study of a popular class of drugs that includes P&G's Prilosec OTC.

    Comment?

  7. heartburn meds heart attackRead the original story w/Photo

    Wednesday Jun 10 | RedOrbit

    Although this discovery is important, Dr. Shah heightens the importance of data-mining techniques for future clinical situations. Using a popular type of medication to treat heartburn or acid reflux disease could increase your risk of having a heart attack, researchers from the Stanford University School of Medicine have discovered in a new, large-scale, data-mining study.

    Comment?

  8. Prilosec, Nexium and Prevacid May Increase Heart Attack RiskRead the original story

    Thursday Jun 11 | InteliHealth

    People who take common antacid drugs called proton pump inhibitors are more likely to have a heart attack than people who don't use these drugs. The rate of heart attacks was 16% to 21% higher.

    Comment?

  9. Heart Attack Risk Increases 16-21% with Use of Common AntacidRead the original story w/Photo

    Thursday Jun 11 | Health News Digest

    Newswise - HOUSTON - - Adults who use proton pump inhibitors are between 16 and 21 percent more likely to experience a heart attack than people who don't use the commonly prescribed antacid drugs, according to a massive new study by Houston Methodist and Stanford University scientists. An examination of 16 million clinical documents representing 2.9 million patients also showed that patients who use a different type of antacid drug called an H2 blocker have no increased heart attack risk.

    Comment?

  10. Some heartburn drugs may boost risk of heart attack, study findsRead the original story w/Photo

    Thursday Jun 11 | Science Blog

    A large data-mining study carried out by investigators at the Stanford University School of Medicine has linked a popular class of heartburn drugs to an elevated risk of heart attack. Proton-pump inhibitors, or PPIs, are among the world's most widely prescribed drugs, with $14 billion in annual sales.

    Comment?

  11. Study links heartburn drugs to higher heart attack riskRead the original story w/Photo

    Wednesday Jun 10 | New Vision

    Popular over-the-counter antacids for treating heartburn, like Prilosec, are linked to a 20 percent higher risk of heart attack Popular over-the-counter antacids for treating heartburn, like Prilosec, are linked to a 20 percent higher risk of heart attack, researchers said Wednesday. The study in the journal PLOS ONE was based on a large data-mining study of nearly three million health records, and was carried out by scientists at Stanford University.

    Comment?

  12. Heartburn drugs may increase risk of heart attackRead the original story w/Photo

    Wednesday Jun 10 | Big News Network.com

    STANFORD, Calif. -- Proton-pump inhibitors, or PPIs, are among the world's most widely prescribed drugs and help tens of millions of people deal with heartburn, but they may also significantly increase the risk for heart attack, according to a new study of medical records.

    Comment?

  13. Some heartburn drugs may carry heightened risk of heart attackRead the original story w/Photo

    Wednesday Jun 10 | Bangor Daily News

    People who take certain popular heartburn medications, such as omeprazole , are at increased risk of heart attack, according to a data mining study by U.S. researchers. The drugs, called proton-pump inhibitors, or PPIs, lower acidity in the stomach and prevent the burning sensation in the esophagus, which indicates acid reflux.

    Comment?

  14. Some heartburn drugs may increase heart attack riskRead the original story w/Photo

    Wednesday Jun 10 | CBS News

    A new study by researchers at Houston Methodist and Stanford University shows that a category of drugs commonly used to fight acid reflux, called proton pump inhibitors, may raise the risk of heart attack. Proton pump inhibitors include such well-known brands such as Prilosec, Nexium, Prevacid and others.

    Comment?

  15. Widely prescribed heartburn drugs may heighten heart-attack riskRead the original story w/Photo

    Wednesday Jun 10 | Stanford

    People with heartburn are at no increased risk of developing heart disease. At least, not unless they're taking the most commonly used class of drugs for treating heartburn.

    Comment?

  16. Heartburn meds, heart attacks linkedRead the original story w/Photo

    Wednesday Jun 10 | The San Diego Union-Tribune

    A popular kind of heartburn medication is linked to a higher rate of heart attacks among those who have already had one, according to a data-mining study by Stanford University School of Medicine researchers. These drugs, which include Prilosec, known generically as omeprazole, belong to a class called proton pump inhibitors.

    Comment?

  17. Study links common heartburn drug to increased heart attack riskRead the original story w/Photo

    Wednesday Jun 10 | Fox News

    One in every 14 Americans uses a proton pump inhibitor - the most common type of heartburn drug- in any given year, but new research that links them to an increased risk of heart attack has prompted scientists to re-evaluate their safety. A study by Stanford University researchers, published Wednesday in the journal PLOS One , linked PPI use to an about 20 percent increased chance of heart attack in patients diagnosed with heartburn.

    Comment?

  18. Common OTC Antacids Increase Risk Of Heart Attack Up To 21%Read the original story w/Photo

    Tuesday Jun 9 | Medical Daily

    On the growing list of things that could possibly give you a heart attack , you can now add antacids. According to a new study published in PLOS ONE, researchers at Houston Methodist and Stanford University found that certain types of antacids using proton pump inhibitors increase your likelihood of suffering a heart attack, regardless of whether you've had preexisting heart conditions.

    Comment?

  19. Pozen making $146M acquisition and will move to IrelandRead the original story

    Monday Jun 8 | Rocky Mount Telegram

    Pozen, a U.S. specialty drugmaker that has struggled to get its cardiovascular drug approved, will buy a Canadian company and move its headquarters to Ireland. Pozen, which is now based in Chapel Hill, N.C., said it plans to pursue other acquisitions.

    Comment?

  20. Pozen making $146M acquisition and will move to IrelandRead the original story

    Monday Jun 8 | ETaiwanNews.com

    Pozen, a U.S. specialty drugmaker that has struggled to get its cardiovascular drug approved, will buy a Canadian company and move its headquarters to Ireland. Pozen, which is now based in Chapel Hill, North Carolina, said it plans to pursue other acquisitions.

    Comment?